Oliver Eng
Associate Professor, Surgery
School of Medicine
School of Medicine
Director, Complex General Surgical Oncology Fellowship
M.D.
University of California, Irvine
Department of Surgery
Orange, CA 92868
Department of Surgery
Orange, CA 92868
Research Interests
Peritoneal surface malignancies, genomic heterogeneity, immune microenvironment, novel therapeutics, disparities in cancer care and access to care
Appointments
2022 - present Associate Professor of Surgery, University of California, Irvine
2018 - 2022 Assistant Professor of Surgery, University of Chicago
2018 - 2022 Assistant Professor of Surgery, University of Chicago
Short Biography
Dr. Oliver Eng is a board-certified UCI Health surgical oncologist who specializes in the treatment of peritoneal surface malignancies, metastatic malignancies, advanced gastrointestinal cancers, sarcomas, and neuroendocrine tumors. He is an expert on the treatment of cancers in the abdomen, particularly cancers that have spread to the peritoneum, the membrane that lines the abdominal cavity. He specializes in complex cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). HIPEC entails delivering high-dose heated chemotherapy in the operating room after surgical removal of visible disease and is effective in different types of cancers. Prior to joining UCI, Dr. Eng was on faculty at the University of Chicago, where he helped lead one of the most robust peritoneal surface malignancy programs in the country.
Dr. Eng has co-authored numerous peer-reviewed manuscripts in journals including Cancer Discovery, Cancer, British Journal of Cancer, and JAMA Surgery. He has received both extramural and intramural funding for his research, which centers on better understanding the molecular and immunologic characteristics of peritoneal tumors. His research aims to develop innovative therapies for metastatic disease and optimize outcomes and care in cancer patients. He has presented his work nationally and internationally, and he has served as a principal investigator or co-investigator on multiple clinical trials. Dr. Eng serves on the editorial board for a variety of scientific journals and has been appointed to a number of national committees. He has received numerous teaching and research awards, and was most recently a recipient of The Lynx Group’s 40 Under 40 in Cancer Award, which recognizes the contributions being made across the field of cancer by emerging leaders nationally.
Dr. Eng has co-authored numerous peer-reviewed manuscripts in journals including Cancer Discovery, Cancer, British Journal of Cancer, and JAMA Surgery. He has received both extramural and intramural funding for his research, which centers on better understanding the molecular and immunologic characteristics of peritoneal tumors. His research aims to develop innovative therapies for metastatic disease and optimize outcomes and care in cancer patients. He has presented his work nationally and internationally, and he has served as a principal investigator or co-investigator on multiple clinical trials. Dr. Eng serves on the editorial board for a variety of scientific journals and has been appointed to a number of national committees. He has received numerous teaching and research awards, and was most recently a recipient of The Lynx Group’s 40 Under 40 in Cancer Award, which recognizes the contributions being made across the field of cancer by emerging leaders nationally.
Publications
https://www.ncbi.nlm.nih.gov/myncbi/oliver.eng.1/bibliography/public/
Professional Societies
American College of Surgeons
Association for Academic Surgery
Society of Surgical Oncology
Society of Asian Academic Surgeons
American Society for Peritoneal Surface Malignancies
Society for Surgery of the Alimentary Tract
Society of University Surgeons
American Board of Surgery
Link to this profile
https://faculty.uci.edu/profile/?facultyId=7056
https://faculty.uci.edu/profile/?facultyId=7056
Last updated
12/12/2025
12/12/2025